Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Early loss to follow-up and mortality of HIV-infected patients diagnosed after the era of antiretroviral treatment scale up: a call for re-invigorating the response in Iran.

Badie BM, Nabaei G, Rasoolinejad M, Mirzazadeh A, McFarland W.

Int J STD AIDS. 2013 Dec;24(12):926-30. doi: 10.1177/0956462413491733. Epub 2013 Aug 6.

PMID:
23970628
2.

Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.

Greig J, O'Brien DP, Ford N, Spelman T, Sabapathy K, Shanks L.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e92-8. doi: 10.1097/QAI.0b013e31824206c7.

PMID:
22134144
3.

Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997-2011).

Mirzaei M, Poorolajal J, Khazaei S, Saatchi M.

Int J STD AIDS. 2013 Nov;24(11):859-66. doi: 10.1177/0956462413486457. Epub 2013 Jul 19.

PMID:
23970604
4.

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.

Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.

J Infect Dis. 2013 Jan 1;207(1):72-9. doi: 10.1093/infdis/jis635. Epub 2012 Oct 24.

PMID:
23100567
5.

Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.

Weigel R, Estill J, Egger M, Harries AD, Makombe S, Tweya H, Jahn A, Keiser O.

AIDS. 2012 Jan 28;26(3):365-73. doi: 10.1097/QAD.0b013e32834ed814.

6.

Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.

Clouse K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, Behets F, Sanne I, Fox MP.

AIDS. 2013 Feb 20;27(4):645-50. doi: 10.1097/QAD.0b013e32835c12f9.

7.

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

CMAJ. 1999 Mar 9;160(5):659-65.

8.

Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women.

Dao CN, Peters PJ, Kiarie JN, Zulu I, Muiruri P, Ong'ech J, Mutsotso W, Potter D, Njobvu L, Stringer JS, Borkowf CB, Bolu O, Weidle PJ.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1149-55. doi: 10.1089/AID.2010.0345. Epub 2011 May 4.

PMID:
21417949
9.

Predictors of mortality among HIV-infected women in Kigali, Rwanda.

Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A, Batungwanayo J, Nsengumuremyi F, Bogaerts J, Hulley S.

Ann Intern Med. 1992 Feb 15;116(4):320-8.

PMID:
1733389
10.
11.

Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse off.

Jespersen S, Hønge BL, Esbjörnsson J, Medina C, da Silva Té D, Correira FG, Laursen AL, Østergaard L, Andersen A, Aaby P, Erikstrup C, Wejse C; Bissau HIV Cohort study group.

Trop Med Int Health. 2016 Feb;21(2):253-62. doi: 10.1111/tmi.12646. Epub 2015 Dec 21.

12.

Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.

Girardi E, Palmieri F, Cingolani A, Ammassari A, Petrosillo N, Gillini L, Zinzi D, De Luca A, Antinori A, Ippolito G.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):326-31.

PMID:
11317073
13.

Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.

Spillane H, Nicholas S, Tang Z, Szumilin E, Balkan S, Pujades-Rodriguez M.

Trop Med Int Health. 2012 Oct;17(10):1255-63. doi: 10.1111/j.1365-3156.2012.03056.x. Epub 2012 Aug 5.

14.

HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania.

Borgdorff MW, Barongo LR, Klokke AH, Newell JN, Senkoro KP, Velema JP, Gabone RM.

Genitourin Med. 1995 Aug;71(4):212-5.

15.

Mortality and treatment outcomes of China's National Pediatric antiretroviral therapy program.

Zhao Y, Li C, Sun X, Mu W, McGoogan JM, He Y, Cheng Y, Tang Z, Li H, Ni M, Ma Y, Chen RY, Liu Z, Zhang F.

Clin Infect Dis. 2013 Mar;56(5):735-44. doi: 10.1093/cid/cis941. Epub 2012 Nov 21.

16.

Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

Schöni-Affolter F, Keiser O, Mwango A, Stringer J, Ledergerber B, Mulenga L, Bucher HC, Westfall AO, Calmy A, Boulle A, Chintu N, Egger M, Chi BH; Swiss HIV Cohort Study; IeDEA Southern Africa.

PLoS One. 2011;6(12):e27919. doi: 10.1371/journal.pone.0027919. Epub 2011 Dec 19.

17.

Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.

Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, Bebawy S, Kheshti A, Sterling TR, Raffanti SP.

J Infect Dis. 2009 Apr 1;199(7):991-8. doi: 10.1086/597124.

PMID:
19220139
18.

Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.

Gutierrez F, Padilla S, Masiá M, Iribarren JA, Moreno S, Viciana P, Muñoz L, Gómez Sirvent JL, Vidal F, López-Aldeguer J, Blanco JR, Leal M, Rodríguez-Arenas MA, Perez Hoyos S; CoRIS-MD.

PLoS One. 2006 Dec 20;1:e89.

19.

Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand.

Fregonese F, Collins IJ, Jourdain G, Lecoeur S, Cressey TR, Ngo-Giang-Houng N, Banchongkit S, Chutanunta A, Techapornroong M, Lallemant M; Program for HIV Prevention and Treatment Study Group.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):91-8. doi: 10.1097/QAI.0b013e31824bd33f.

PMID:
22293548
20.

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.

Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G; ANRS CO8 APROCO-COPILOTE Cohort Study Group.

AIDS. 2012 Jan 28;26(3):303-14. doi: 10.1097/QAD.0b013e32834e8776.

PMID:
22089377

Supplemental Content

Support Center